Drug Type Oncolytic virus |
Synonyms- |
Target |
Action modulators, inhibitors |
Mechanism CCL5 modulators(C-C motif chemokine 5 modulators), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | - | 25 Jan 2022 |





